⌘K

Login Start Free

Home/Filings/4/0001209191-23-001310

4//SEC Filing

Rouan Sarah Kathryn 4

Accession 0001209191-23-001310

CIK 0001607678other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 6:11 PM ET

Size

5.1 KB

Accession

0001209191-23-001310

Insider Transaction Report

Form 4

Period: 2023-01-03

Viking Therapeutics, Inc.VKTX

Rouan Sarah Kathryn

Director

Transactions

Award
Stock Option (Right to Buy)
2023-01-03+22,000→ 22,000 total
Exercise: $8.52From: 2024-01-03Exp: 2033-01-03→ Common Stock (22,000 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viking Therapeutics, Inc.

CIK 0001607678

Entity typeother

Related Parties

1

filerCIK 0001761366

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 6:11 PM ET
Size: 5.1 KB

View on SEC.gov